Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding. - Wikidata - awgldk - TriplyDB

Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.

Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.

http://www.wikidata.org/entity/Q36898276

about

Structural basis for potency differences between GDF8 and GDF11.Activin A more prominently regulates muscle mass in primates than does GDF8.Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1 Utilizing BMP-2 muteins for treatment of multiple myeloma The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis.Novel Anti-fibrotic Therapies.Towards a cure for Fibrodysplasia ossificans progressiva.Follistatin is critical for mouse uterine receptivity and decidualization.BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration.Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.Physiological Fluid Flow Moderates Fibroblast Responses to TGF-β1.TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family

P2860

Q31813087-52B6E6A0-F63D-4329-B1F2-0F1A34DF3C5E Q33630598-1013694F-447E-4227-9B8D-FD3C12673082 Q34557333-7F06A747-F465-41ED-9745-A574A0886216 Q36367921-67E8E2B2-9252-4EE9-A143-93BA779793E4 Q37182424-2CE0BF2A-5814-4156-8658-C4AB2F0833F5 Q38719223-091388BE-9B04-408F-B01B-0AF62DAC41FB Q38760540-78EE122B-AF5A-4DFA-BA54-9E38807C8063 Q39377055-6BE590EC-4BF6-415E-9983-D14D7D0F5897 Q42370380-54E2CB32-7302-4BA9-8D40-4A9A0395C365 Q46566010-39E848B1-7A28-4C62-A62C-0E7C03D70A6A Q47237512-C82B7D71-22FF-4C3E-B6F1-10DFC0429E25 Q47842359-42A73AF6-72BD-4D33-BDDC-4707B3E1797D Q51386683-7FA227BB-9663-4D14-8EC4-AEF7B6669544 Q57166510-C8AF565C-867F-4BF0-96D6-84F242212353

P2860

Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.

http://www.wikidata.org/entity/Q36898276

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Transforming Growth Factor-β F ...... for Type II Receptor Binding.

@en

type

label

Transforming Growth Factor-β F ...... for Type II Receptor Binding.

@en

prefLabel

Transforming Growth Factor-β F ...... for Type II Receptor Binding.

@en

P1433

Q36898276-62C7ED80-1DF3-4F61-9A78-620962E4CBB5

P1476

Q36898276-97FBD98C-5947-437B-993F-0DFE2D57F24B

P2093

Q36898276-19A3316E-FB1B-46F2-8256-501AF476FEAC

Q36898276-B36CA2CB-2F69-4211-B7E2-41B6842B7241

P2860

Q36898276-09B2434D-EAA0-44F0-AB93-BD9A3FE6F79A

Q36898276-0BFD7919-B2CD-4406-AD4E-7AAC3D8388C0

Q36898276-0E683E4D-34EB-43B0-8B52-CFAF33E73B28

Q36898276-10EEBE08-B783-4B8A-9326-A7BCD993B78B

Q36898276-1E0F1B6A-D8C9-4FAD-8B5D-58E8292D7984

Q36898276-2029D731-7043-4F10-8BFE-406EE9246859

Q36898276-22E86175-EF68-4B3C-89AE-E84DE8D91571

Q36898276-24644494-92AC-4F7B-9570-4D4876B3F18A

Q36898276-25BF1014-04C6-4402-999E-7CBB86484CC3

Q36898276-265DF65C-4692-40BE-A5C9-542C5B0BAD3A

P304

Q36898276-EB37278C-DFF0-434C-AC6B-46831C740230

P31

Q36898276-BC7E434F-CF68-4FE0-8CBC-0373D854EC47

P356

Q36898276-9617CEDC-42A5-4D6C-8DA0-41440A85946A

P407

Q36898276-836B0CEE-F299-4172-915A-15A3C8ED41A1

P433

Q36898276-954F32C6-12A7-46AE-9595-09EC10681A54

P478

Q36898276-D8F5FE33-86D9-468F-9649-C5004D54E782

P50

Q36898276-1AC5EBDE-331F-45F5-AE6F-47BCC09D3C85

Q36898276-A7401F1C-679B-46E8-BA4C-C3180512BDC1

P577

Q36898276-3C158576-7DC4-4047-AEA8-5B4382B8A6BD

P698

Q36898276-98C17896-2E97-4EED-ACAC-50C852694902

P932

Q36898276-5DA78655-9268-4EE4-9895-CE1401105111

P356

JBC.M115.713487

P1433

Journal of Biological Chemistry

P1476

Transforming Growth Factor-β F ...... g for Type II Receptor Binding

@en

P2093

Erik Martinez-Hackert

http://www.w3.org/2001/XMLSchema#string

Senem Aykul

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-beta signal transduction

Crystal structure of the BMP-2-BRIA ectodomain complex

Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor

Activation of signalling by the activin receptor complex

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding

Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation

The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding

P304

10792-10804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M115.713487

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P50

Erik Martinez-Hackert

P577

2016-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26961869

http://www.w3.org/2001/XMLSchema#string

P932

4865925

http://www.w3.org/2001/XMLSchema#string